Johannes Gutenberg-Universität Mainz
- 6131/39-0
Wahl, Alisha; Nagel, Michael; Labenz, Christian et al.
NON-ALCOHOLIC FATTY LIVER DISEASE IS HIGHLY PREVALENT IN PATIENTS LIVING WITH HUMAN DEFICIENCY VIRUS (HIV) IN GERMANY.HEPATOLOGY. Bd. 70. 2019 S. 1084A-1084A
Schmiedeke, E.; Schaefer, S.; Aminoff, D. et al.
Non-financial conflicts of interest: contribution to a surgical dilemma by the European Reference Networks for Rare DiseasesPEDIATRIC SURGERY INTERNATIONAL. Bd. 35. H. 9. 2019 S. 999-1004
Lang, B. M.; Zimmer, S.; Weidenthaler-Barth, B.
Non-healing Ulceration on the Sole of the FootHAUTARZT. Bd. 70. H. 5. 2019 S. 383-385
Simon, Johanna; Bauer, Kristin N.; Langhanki, Jens et al.
Noncovalent Targeting of Nanocarriers to Immune Cells with Polyphosphoester-Based Surfactants in Human Blood PlasmaADVANCED SCIENCE. Bd. 6. H. 22. 2019
Aptel, Florent; Pfeiffer, Norbert; Schmickler, Stefanie et al.
Noninferiority of Preservative-free Versus BAK-preserved Latanoprost-timolol Fixed Combination Eye Drops in Patients With Open-angle Glaucoma or Ocular HypertensionJOURNAL OF GLAUCOMA. Bd. 28. H. 6. 2019 S. 498-506
Boerschel, Christin S.; Ruebsamen, Nicole; Ojeda, Francisco M. et al.
Noninvasive peripheral vascular function and atrial fibrillation in the general populationJOURNAL OF HYPERTENSION. Bd. 37. H. 5. 2019 S. 928-934
Traussnigg, Stefan; Schattenberg, Jorn M.; Demir, Munevver et al.
Norursodeoxycholic acid versus placebo in the treatment of non-alcoholic fatty liver disease: a double-blind, randomised, placebo-controlled, phase 2 dose-finding trialLANCET GASTROENTEROLOGY & HEPATOLOGY. Bd. 4. H. 10. 2019 S. 781-793
Oancea-Castillo, Liliana; Bahr, Kerstin; Regnier-Vigouroux, Anne et al.
Novel combination of repurposed drugs induces complete cell invasion arrest of glioblastoma in vitroCANCER RESEARCH. Bd. 79. H. 13. 2019
Staubitz, Julia Isabelle; Schad, Arno; Springer, Erik et al.
Novel rearrangements involving the RET gene in papillary thyroid carcinomaCANCER GENETICS. Bd. 230. 2019 S. 13-20
Bihi, Mahjoub
Novel RNA-based adjuvants with strong immunostimulatory activities improve the efficacy of VLP-based cancer vaccinesMainz: Univ. 2019 0 S.